Genetic Modifiers of p53: Opportunities for Breast Cancer Therapies | Oncotarget



October 24, 2023

  • Share
  • Oncotarget published this trending editorial perspective on March 24, 2023 in Volume 14, entitled, “Genetic modifiers of p53: opportunities for breast cancer therapies" by researchers from the Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA; Pioneer Valley Life Sciences Institute and Rays of Hope Center for Breast Cancer Research, Springfield, MA. DOI - Correspondence to - D. Joseph Jerry - Sign up for free Altmetric alerts about this article - Subscribe for free publication alerts from Oncotarget - Keywords - cancer, p53, Li-Fraumeni syndrome, genetic modifiers, breast cancer, DNA repair About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit and connect with us: SoundCloud - Facebook - X - Instagram - YouTube - LinkedIn - Pinterest - Reddit - Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Cancer ResearchCell Science

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.